Durvalumab vs Enalapril

## Durvalumab vs Enalapril: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Enalapril**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Enalapril**: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Enalapril — 11 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Enalapril — C20H28N2O5.

**Molecular Weight**: Durvalumab — N/A; Enalapril — 376.4470 g/mol.

**Type**: Durvalumab — Antibody; Enalapril — Small molecule.